跳至主要内容
临床试验/NCT04603859
NCT04603859招募中不适用

When to INDuce for OverWeight? - a Randomised Controlled Trial (WINDOW)

University of Aarhus13 个研究点 分布在 1 个国家目标入组 1,900 人开始时间: 2020年10月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
1,900
试验地点
13
主要终点
Caesarean section

研究概览

简要总结

The rate of overweight and obese women becoming pregnant is increasing. Obesity in pregnancy along with delivery by cesarean section in obese women is associated with several complications as compared to normal weight women. The longer the woman is pregnant, the longer she is at risk. In an otherwise low-risk pregnant woman at term, it is an ongoing clinical dilemma, whether the benefits of elective induction of labor and termination of the pregnancy will outweigh the potential harms from concomitant induction and delivery process. The proposed study is a randomized controlled study of elective induction versus expectant management in obese women. The study will be carried out as a national multicenter study with inclusion of 1900 participants from Danish delivery wards. The null hypothesis is that the caesarean section rate is similar with elective induction of labor at 39 weeks of gestation, compared with expectant management among pregnant women with pre- or early pregnancy BMI≥30.

详细描述

Background The World Health Organization (WHO) defines overweight as a body mass index (BMI) of ≥25 kg/m2 and obesity as a BMI of ≥30 kg/m2. Overweight and obesity are rising dramatically worldwide. In fertile women, the prevalence of obesity is one third in the United States, 20% in the United Kingdom, and 12-13% in Denmark. The association between obesity in pregnancy and the risk of gestational complications increases with increasing BMI. Among other complications, obesity in pregnancy is associated with increased risk of caesarean delivery. Delivery by caesarean section further adds significant risks of wound infection or other infectious morbidity in obese women as compared to normal weight women. The longer the woman is pregnant, the longer the risk of pregnancy complications remains. In an otherwise low-risk pregnant woman at term, it is an on-going clinical dilemma, whether the benefits of elective induction of labor (eIOL) and termination of the pregnancy will outweigh the potential harms from the concomitant induction and delivery process. Regarding delivery complications, based on data from historical cohorts, eIOL has traditionally been associated with an increased risk of caesarean section and instrumental delivery. Therefore, expectant management has been the preferred clinical option. This interpretation has now been challenged by a randomized trial (ARRIVE) with >6000 low-risk pregnant women where eIOL at 39 weeks of gestation was associated with lower caesarean delivery rates. There are no randomized studies in obese women, but two larger observational studies did find lower odds of caesarean delivery in obese women with eIOL as compared to awaiting labor onset. Hence, a randomized trial that would compare caesarean delivery among obese women whose labor is induced with those expectantly managed is warranted. The proposed study will provide new and important knowledge into the area of induction of labor among overweight and obese women with potential great international impact for the future raising number of pregnant women in this subgroup.

With this trial, the investigators aim to compare the risk of caesarean section in obese (BMI ≥ 30 kg/m2), but otherwise low-risk women with eIOL as compared to expectant management.

Materials and methods

The study is a multicenter randomized controlled trial with an allocation ratio of 1:1 in the two following arms:

  • Intervention arm/elective induction of labor in pregnancy at 39 gestational week and 0 to 3 days: Induction is performed according to local policy for induction of labor.
  • Comparison arm/expectant management: Waiting for spontaneous onset of labor unless a situation develops necessitating either induction of labor or caesarean section.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women with pre- or early pregnancy BMI ≥ 30 kg/m2

排除标准

  • Legal or ethical considerations: maternal age <18 years, language difficulties requiring an interpreter or translator
  • Multiple pregnancy
  • Previous caesarean section
  • Uncertain gestational age, defined as gestational age determined by other measurements than the Crown-Rump length (CRL) Measurement
  • Planned elective caesarean section at time of randomisation
  • Fetal contraindications to IOL at time of randomisation: e.g. non-cephalic presentation, or other fetal conditions contraindicating vaginal delivery
  • Fetal contraindications to expectant management at time of randomisation
  • Maternal contraindications to IOL at time of randomisation: e.g. placenta previa/accreta, vasa previa
  • Maternal contraindications to expectant management at time of randomisation: e.g. maternal medical conditions, ultrasonically diagnosed oligohydramnios (DVP< 2 cm), signs of labour including pre-labour rupture of membranes (PROM)

研究组 & 干预措施

Elective induction of labour

Experimental

Elective induction of labour at 39 gestational weeks and 0 to 3 days.

干预措施: Elective induction of labor at 39 gestational weeks and 0 to 3 days (Procedure)

Expectant management

No Intervention

Awaiting spontaneous labor.

结局指标

主要结局

Caesarean section

时间窗: At delivery

number (no.)

次要结局

  • Maternal death(Enrollment to 30 days postpartum)
  • Hysterectomy(At delivery to 30 days postpartum)
  • Neonatal trauma composite including any of the following;(At delivery to 28 days of life)
  • Other treatment during neonatal admission(0-28 days of life)
  • Maternal admission to Intensive Care Unit(Enrollment to 30 days postpartum)
  • Postpartum morbidity(0-30 days postpartum)
  • Maternal cardiopulmonary arrest(Enrollment to 30 days postpartum)
  • Mode of delivery if not by caesarean(At delivery)
  • Vaginal assisted delivery(At delivery)
  • Indication for caesarean section (more than one indication is possible)(At delivery)
  • Damage to internal organs (bladder, bowel or ureters)(At delivery to 30 days postpartum)
  • Primary neonatal composite including any of the following;(Enrollment to 28 days of life)
  • Neonatal asphyxia composite including any of the following;(At delivery to 28 days of life)
  • Respiratory support during neonatal admission(0-28 days of life)
  • Indication for vaginal assisted delivery (more than one is possible)(At delivery)
  • Complications(At delivery)
  • Apgar score at 5 minutes(5 minutes of life)
  • Neonatal admission(0-72 hours of life)
  • Mode of delivery(At delivery)
  • Use of epidural(At delivery)
  • Uterine scar dehiscense or rupture(At delivery)
  • Postpartum haemorrhage(0-2 hours postpartum)
  • Components of the primary neonatal composite will additionally be reported separately(Enrollment to 28 days of life)
  • Umbilical cord arterial and venous blood sample (allow missing data)(0-30 minutes of life)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lise Krogh

Principal Investigator

University of Aarhus

研究点 (13)

Loading locations...

相似试验